10X Genomics, Inc. (TXG)
93.50
+4.74
(+5.34%)
USD |
NASDAQ |
Oct 02, 16:00
94.00
+0.50
(+0.53%)
After-Hours: 20:00
10X Genomics Cash from Operations (TTM) : 127.08M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 127.08M |
| March 31, 2026 | 127.82M |
| December 31, 2025 | 136.05M |
| September 30, 2025 | 88.52M |
| June 30, 2025 | 66.95M |
| March 31, 2025 | 56.74M |
| December 31, 2024 | 6.664M |
| September 30, 2024 | 39.17M |
| June 30, 2024 | -7.775M |
| March 31, 2024 | -26.80M |
| December 31, 2023 | -15.20M |
| September 30, 2023 | -27.23M |
| June 30, 2023 | -11.49M |
| Date | Value |
|---|---|
| March 31, 2023 | -16.93M |
| December 31, 2022 | -33.61M |
| September 30, 2022 | -41.52M |
| June 30, 2022 | -58.18M |
| March 31, 2022 | -38.09M |
| December 31, 2021 | -21.37M |
| September 30, 2021 | -157.35M |
| June 30, 2021 | -186.77M |
| March 31, 2021 | -219.40M |
| December 31, 2020 | -217.90M |
| September 30, 2020 | -81.02M |
| June 30, 2020 | -10.87M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Twist Bioscience Corp. | -53.07M |
| Tempus AI, Inc. | -238.18M |
| Personalis, Inc. | -92.30M |
| Alamar Biosciences, Inc. (California) | -56.62M |
| Beam Therapeutics, Inc. | -359.38M |